Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Extended Deep Venous Thrombosis Prophylaxis in Gynecologic Oncology Surgery With Intermittent Compression Devices (ICD) With or Without Postoperative Arixtra [fondaparinux sodium]: A Randomized Controlled Trial.

Trial Profile

Extended Deep Venous Thrombosis Prophylaxis in Gynecologic Oncology Surgery With Intermittent Compression Devices (ICD) With or Without Postoperative Arixtra [fondaparinux sodium]: A Randomized Controlled Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2012 Actual patient number changed from 8 to 7 as reported by ClinicalTrials.gov.
    • 08 Mar 2012 Planned end date changed from 1 Jun 2011 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 28 Oct 2010 Planned end date changed from 1 Jun 2008 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top